Photodegradable Hydrogel Microfluidic Cell Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current microfluidic devices for capturing and analyzing rare cell populations, such as circulating tumor cells, are limited by their inability to selectively release individual cells for downstream analysis and culture, often damaging cells with chemical or mechanical methods, and existing methods like alginate layers are not suitable for all conditions.

Innovation Solution

The development of microfluidic capture devices with photodegradable hydrogels, specifically poly(ethylene glycol) (PEGdiPDA) based hydrogels, that allow for spatial and temporal control of cell release using visible wavelength light, enabling selective capture and release of mammalian cells with cytocompatibility.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If chemical gradients or shear forces are employed to disrupt cell-material interactions, then captured cells can be released, but cells are damaged or gene expression is rapidly altered

Engineering Contradiction:
Improvecell release capabilityVSAvoidcell damage
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent replaces mechanical (shear forces) and chemical disruption methods with a photodegradable hydrogel system. The hydrogel contains photolabile crosslinks that can be selectively cleaved by UV light irradiation, enabling cell release without mechanical stress or harmful chemical treatment. This optical control mechanism substitutes the harmful mechanical/chemical release methods while preserving cell integrity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the chemical parameter of the hydrogel crosslinks from stable to photolabile. By incorporating photolabile crosslinking agents that can be cleaved by UV light, the material properties are dynamically changed upon light exposure, enabling controlled cell release without damaging the cells. This parameter change allows the same material to provide both strong adhesion during capture and gentle release upon illumination.

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If alginate layers are used for cell capture and release, then cells can be recovered, but the method cannot be conducted in the presence of calcium chelating ligands and calcium treatment alters cell signaling

Engineering Contradiction:
Improvecell recoveryVSAvoidcompatibility with calcium chelating ligands
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The patent changes the chemical basis of the hydrogel from calcium-dependent (alginate) to photodegradable crosslinks. This parameter change makes the system independent of calcium ions, allowing it to function in the presence of calcium chelating ligands like EDTA and citrates. The photolabile crosslinks provide a different mechanism for cell release that does not involve calcium signaling pathways.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces photolabile crosslinking agents as an intermediary mechanism between cell capture and release. Instead of relying on calcium ion removal or addition, the system uses light-activated cleavage of specific chemical bonds in the hydrogel network. This intermediary photodegradation pathway bypasses the limitations of calcium-based systems and enables cell release in diverse chemical environments.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If the whole capture surface is disrupted with enzyme treatment, then captured cells can be released, but individual cell release is not possible

Engineering Contradiction:
Improvecell releaseVSAvoidspatial control over cell release
Core Design Contradiction:
Ease of operationVSEase of manufacture

Solution Approach 1:

The patent applies local quality by enabling spatially selective photodegradation of the hydrogel. UV light can be focused on specific regions of the capture surface, causing localized cleavage of photolabile crosslinks and releasing only cells in those illuminated areas. This local control capability allows individual or small groups of cells to be released while other cells remain captured, enabling selective isolation of specific cells from heterogeneous populations.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent segments the cell release process by allowing different regions of the capture surface to be released independently through localized UV irradiation. Instead of treating the entire surface uniformly, the system can be divided into multiple zones with independent release control. This segmentation enables sequential or selective release of different cell populations based on their spatial distribution on the capture surface.

Inventive Principle:
Principle #1Segmentation

4Quantity of substance

If microfluidic devices use traditional geometry, then nanoliter to microliter scale volumes can be processed, but milliliters of whole blood cannot be processed to capture rare circulating tumor cells

Engineering Contradiction:
Improvevolume processing capacityVSAvoiddevice geometry adjustments
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent enhances the universality of the microfluidic device by making the capture surface geometry adaptable through photodegradable hydrogels. The hydrogel can be formed in various microfluidic channel geometries and then selectively released in different patterns. This multi-functionality allows the same device platform to process different volumes (from nanoliters to milliliters) and capture rare cells while maintaining the ability to selectively release individual cells for downstream analysis.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the precise capture and release of individual cells, preserving their integrity for further analysis and culture, and allows for the analysis of rare cell populations with improved spatial control and reduced damage.

Implementation Method 1

The free radicals produced initiate a polymerization reaction, whereby the first linking moiety of the L groups of the macromer and the second linking moiety of the cell binding moiety are incorporated into polymer chains

Methodology Applied
Scientific EffectPhotopolymerization: Photopolymerisation

Implementation Method 2

longwave UV light induced gel erosion with both spatial and temporal precision

Methodology Applied
Scientific EffectPhotodegradation: Photodissociation

Data Source

PatentUS11262361B2Selective capture and release of rare mammalian cells using photodegradable hydrogels in a microfluidic platform
Publication Date: 2022.03.01 THE GENERAL HOSPITAL CORP
  • US11262361B2 patent drawing
  • US11262361B2 patent drawing
  • US11262361B2 patent drawing

AI summary

Disclosed herein are photodegradable hydrogels and associated kits for selectively capturing and releasing cells. The hydrogels result from cross linking in the presence of a photoinitiator (1) a macromer having a polymeric backbone structure, a photo labile moiety, and a first linking moiety, and (2) a cell-binding moiety having a second linking moiety. These two components are cross-linked by a polymerization reaction of the linking moieties to form a photodegradable hydrogel incorporating the cell-binding moiety within the hydrogel. Also disclosed are methods of making the hydrogels, and methods of using the hydrogels for selectively capturing and releasing cells and for detecting cells in a fluid. Such methods can be used to detect the presence and quantity of certain rare cell types in a biological fluid.